April 11, 2024 3-5PM ET
Thursday on The Robert Scott Bell Show:
Special Guest: Jonathan Emord
For the past 37 years, Jonathan W. Emord has litigated against the federal bureaucracy, winning over and over again. Ron Paul calls Jonathan “an expert in constitutional theory and history” and “an expert litigator with a long string of legal victories over the federal bureaucracy.” George Noory calls him “a Knight in Shining Armor” and “a warrior out to save our rights.” Congressmen Dan Burton and John Doolittle describe him as “an intellectual warrior for the rights and freedoms of people in America.” Jonathan has a unique, detailed knowledge of the federal bureaucracy, the deep state. He knows how to defeat it. Jonathan graduated from the University of Illinois (BA, political science and history, 1982) and DePaul University College of Law (JD, 1985). He served as an attorney in the Federal Communications Commission during the Reagan administration. A leading constitutional law and litigation expert, he is the author of five critically acclaimed books. He has won more cases against the Food and Drug Administration in federal court than any other attorney in American history, earning him the nickname “FDA Dragon Slayer.” He is a columnist for Townhall.com, PJ Media.com, Americangreatness.com, and the U.S.A. Today Magazine. He frequently appears on national radio and television programs. He is married to Sheryl Emord, and they have two children, twins Justice and Angelica. They reside in Clifton, Virginia.

Rep. Jackson Lee ripped after defending her moon gaffe and blaming it on GOP: ‘Vote better people’: Rep. Sheila Jackson Lee faced criticism after inaccurately stating the moon is “made up mostly ofgases” during a speech at a Houston high school. The Texas congresswoman, who also referred to the moon as a “planet,” was speaking ahead of a solar eclipse. After her comments went viral, Jackson Lee attributed the backlash to Republicans focusing on trivial matters rather than pressing issues like prenatal care and affordable housing. She claimed her mention of gases was a reference to the sun, not the moon. Critics, including public figures and commentators, mocked her response, highlighting her previous role on the House Science Committee’s space subcommittee and questioning her competency.
Exactly What Are WHO Member States Voting for?: As WHO Member States approach voting on a new Pandemic Agreement and amendments to theInternational Health Regulations (IHR), the absence of a universally agreed definition of “pandemic” raises significant concerns. The term’s ambiguity could potentially lead to expansive authority granted to the WHO without a clear understanding of the criteria or conditions that constitute a pandemic. Historical perspectives on pandemics emphasize the variability in severity and impact, further complicating the establishment of a concrete framework for future pandemic preparedness and response. The article highlights the potential consequences of conflating pandemic preparedness with Public Health Emergencies of International Concern (PHEIC), suggesting a need for clarity and specificity in defining pandemics to avoid confusion and ensure effective and equitable global health governance.
Chevron, Murthy, and ‘Supreme’ Hypocrisy: This analysis discusses the implications of two Supreme Court cases on the powers of government agencies and the issue of censorship. The article contrasts the court’s consideration of rolling back the Chevron deference, which currently grants broad interpretive authority to regulatory agencies, with its handling of the Murthy v. Missouri case concerning government censorship. The piece argues that while Chevron and government censorship may seem unrelated, both centralize state power by endorsing agency expertise over law interpretation and enforcing a narrow view of truth through censorship. Highlighting recent efforts to control the narrative around COVID-19 and the 2020 election, the author suggests that allowing such unchecked government control poses a direct threat to free speech and democracy. The potential rollback of Chevron deference juxtaposed with the court’s seeming tolerance for censorship reflects a critical tension in American legal and political philosophy, raising concerns about the future of individual freedoms and the balance of power between government entities and the public.
Ten Doctors on FDA Panel Reviewing Abbott Heart Device Had Financial Ties With Company: A significant number of doctors on an FDA advisory panel evaluating an Abbott heart device, specifically theTriClip G4 System, had previously received payments from Abbott, raising concerns about potential conflicts of interest. The Open Payments database revealed that 10 out of 14 voting members of the panel had financial ties to Abbott, with the total payments amounting to approximately $650,000 from 2016 to 2022. Despite these connections, the panel voted almost unanimously in favor of the device’s benefits outweighing its risks, leading to FDA approval. Critics argue that such financial relationships should have been disclosed for transparency, as they could influence the objectivity of the committee’s decision-making. The situation underscores ongoing debates about the influence of the medical industry on regulatory processes and the importance of ensuring advisory panel members’ impartiality.
Hour 2
EXCLUSIVE: Suspended Doctor Reveals How Regulators Punished Her For Prescribing Ivermectin: Dr. My Le Trinh, a General Practitioner in New South Wales, Australia, was suspended by medical regulators for prescribing Ivermectin to treat COVID-19. Dr. Trinh contends that the suspension was unjust, stemming from false complaints. She describes a convoluted process involving unusual complaint filings, including one from a junior doctor under directive and another fabricated one from an individual named “John Smith.” Dr. Trinh argues that her use of Ivermectin, following the Front Line COVID-19 Critical Care Alliance protocol, was effective in treating a patient with COVID-19, challenging the regulators’ decision to suspend her license based on what she views as fraudulent complaints. The controversy highlights ongoing debates around the use of Ivermectin for COVID-19 and the actions of regulatory bodies in response to such treatments.








